CORT silencing impairs migration and invasion: validation of a glycosylation-based risk model (CORT/LPAR5/CEBPA/MYH10/MAGEA11) in osteosarcoma

We developed a useful risk model and this study provided new insights for OS therapy.

Authors

Institutions

Publication Details

Journal
European journal of medical research
Published
2026-01-05
DOI
https://doi.org/10.1186/s40001-025-03744-4
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

CORT silencing impairs migration and invasion: validation of a glycosylation-based risk model (CORT/LPAR5/CEBPA/MYH10/MAGEA11) in osteosarcoma

Xiangming Li, Xinyu Gu, Fuqiang Ma, Yanhua Song et al.
European journal of medical research
Sarcoma Diagnosis and Treatment
article

CORT silencing impairs migration and invasion: validation of a glycosylation-based risk model (CORT/LPAR5/CEBPA/MYH10/MAGEA11) in osteosarcoma

Xiangming Li, Xinyu Gu, Fuqiang Ma, Yanhua Song, Jiachun Sun, Zihan Yang
article en

Abstract

We developed a useful risk model and this study provided new insights for OS therapy.

European journal of medical researchVol. 31(1)
Henan University of Science and Technology (CN), Zhengzhou City Hospital (CN), First Affiliated Hospital of Henan University of Science and Technology (CN)
Openalex Percentile: Top 97%
Sarcoma Diagnosis and Treatment
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.